188 related articles for article (PubMed ID: 31938994)
1. iASPP-Mediated ROS Inhibition Drives 5-Fu Resistance Dependent on Nrf2 Antioxidative Signaling Pathway in Gastric Adenocarcinoma.
Wen L; Yang S; Li P; Chen R; Wang Q; Kaspo B; Fan H; Hu J
Dig Dis Sci; 2020 Oct; 65(10):2873-2883. PubMed ID: 31938994
[TBL] [Abstract][Full Text] [Related]
2. iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding.
Ge W; Zhao K; Wang X; Li H; Yu M; He M; Xue X; Zhu Y; Zhang C; Cheng Y; Jiang S; Hu Y
Cancer Cell; 2017 Nov; 32(5):561-573.e6. PubMed ID: 29033244
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro.
Yu J; Li L; Huang C
Med Sci Monit; 2017 Nov; 23():5542-5549. PubMed ID: 29161238
[TBL] [Abstract][Full Text] [Related]
4. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.
Kang KA; Piao MJ; Kim KC; Kang HK; Chang WY; Park IC; Keum YS; Surh YJ; Hyun JW
Cell Death Dis; 2014 Apr; 5(4):e1183. PubMed ID: 24743738
[TBL] [Abstract][Full Text] [Related]
6. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.
Shibata T; Kokubu A; Gotoh M; Ojima H; Ohta T; Yamamoto M; Hirohashi S
Gastroenterology; 2008 Oct; 135(4):1358-1368, 1368.e1-4. PubMed ID: 18692501
[TBL] [Abstract][Full Text] [Related]
7. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate.
Kweon MH; Adhami VM; Lee JS; Mukhtar H
J Biol Chem; 2006 Nov; 281(44):33761-72. PubMed ID: 16950787
[TBL] [Abstract][Full Text] [Related]
8. Quercetin reverses 5-fluorouracil resistance in colon cancer cells by modulating the NRF2/HO-1 pathway.
Tang Z; Wang L; Chen Y; Zheng X; Wang R; Liu B; Zhang S; Wang H
Eur J Histochem; 2023 Aug; 67(3):. PubMed ID: 37548240
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-Gelatin-EGCG Nanoparticle-Meditated LncRNA TMEM44-AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5-FU Resistance in Gastric Cancer.
Zhou M; Dong J; Huang J; Ye W; Zheng Z; Huang K; Pan Y; Cen J; Liang Y; Shu G; Ye S; Lu X; Zhang J
Adv Sci (Weinh); 2022 Aug; 9(22):e2105077. PubMed ID: 35717675
[TBL] [Abstract][Full Text] [Related]
10. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
11. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway].
Wang LJ; Wang SG; Deng TX
Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 overexpression predicts prognosis and 5-FU resistance in gastric cancer.
Hu XF; Yao J; Gao SG; Wang XS; Peng XQ; Yang YT; Feng XS
Asian Pac J Cancer Prev; 2013; 14(9):5231-5. PubMed ID: 24175806
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil inhibits cell migration by induction of Sestrin2 in colon cancer cells.
Seo K; Ki SH; Park EY; Shin SM
Arch Pharm Res; 2017 Feb; 40(2):231-239. PubMed ID: 28028695
[TBL] [Abstract][Full Text] [Related]
14. Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells.
Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan V
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):601-12. PubMed ID: 25708948
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial GRIM-19 deficiency facilitates gastric cancer metastasis through oncogenic ROS-NRF2-HO-1 axis via a NRF2-HO-1 loop.
Wang X; Ye T; Xue B; Yang M; Li R; Xu X; Zeng X; Tian N; Bao L; Huang Y
Gastric Cancer; 2021 Jan; 24(1):117-132. PubMed ID: 32770429
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury.
Li Y; Cao Y; Xiao J; Shang J; Tan Q; Ping F; Huang W; Wu F; Zhang H; Zhang X
Cell Death Differ; 2020 Sep; 27(9):2635-2650. PubMed ID: 32203170
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
18. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q
Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of iASPP ameliorates hypoxia/reoxygenation-induced apoptosis and oxidative stress in cardiomyocytes by upregulating Nrf2 signaling.
Bai B; Zeng G; Chen R; Ai Y; Qiang H
J Biochem Mol Toxicol; 2021 Mar; 35(3):e22686. PubMed ID: 33332723
[TBL] [Abstract][Full Text] [Related]
20. Rofecoxib augments anticancer effects by reversing intrinsic multidrug resistance gene expression in BGC-823 gastric cancer cells.
Zhu FS; Chen XM; Huang ZG; Wang ZR; Zhang DW; Zhang X
J Dig Dis; 2010 Feb; 11(1):34-42. PubMed ID: 20132429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
